Skip to main content
Elsevier
View Cart
My account

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

BooksJournals

    • Catecholamines: Bridging Basic Science with Clinical Medicine

      • 1st Edition
      • Volume 42
      • October 20, 1997
      • English
      • eBook
        9 7 8 0 0 8 0 5 8 1 3 4 7
      This volume in Advances in Pharmacology focuses on all aspects of catecholamine research, from very basic to medical. It is broad based and covers many areas within physiology and medicine.

    • Advances in Drug Research

      • 1st Edition
      • Volume 28
      • July 2, 1996
      • English
      • Hardback
        9 7 8 0 1 2 0 1 3 3 2 8 4
      • eBook
        9 7 8 0 0 8 0 5 2 6 7 1 3
      This volume continues the trend for Advances in Drug Research of shorter, but more frequent volumes. In line with the tradition of the series, chapters on general themes are interspersed with chapters on specific drug classes and targets.

    • Neural Networks in QSAR and Drug Design

      • 1st Edition
      • August 9, 1996
      • James Devillers
      • English
      • Paperback
        9 7 8 0 1 2 3 8 8 4 5 9 6
      • eBook
        9 7 8 0 0 8 0 5 3 7 3 8 2
      Comprehensive and impeccably edited, Neural Networks in QSAR and Drug Design is the first book to present an all-inclusive coverage of the topic. The book provides a practice-oriented introduction to the different neural network paradigms, allowing the reader to easily understand and reproduce the results demonstrated. Numerous examples are detailed, demonstrating a variety of applications to QSAR and drug design.The contributors include some of the most distinguished names in the field, and the book provides an exhaustive bibliography, guiding readers to all the literature related to a particular type of application or neural network paradigm. The extensive index acts as a guide to the book, and makes retrieving information from chapters an easy task. A further research aid is a list of software with indications of availablility and price, as well as the editors scale rating the ease of use and interest/price ratio of each software package. The presentation of new, powerful tools for modeling molecular properties and the inclusion of many important neural network paradigms, coupled with extensive reference aids, makes Neural Networks in QSAR and Drug Design an essential reference source for those on the frontiers of this field.

    • Antidiabetic Agents: Recent Advances in their Molecular and Clinical Pharmacology

      • 1st Edition
      • Volume 27
      • May 8, 1996
      • English
      • Hardback
        9 7 8 0 1 2 0 1 3 3 2 7 7
      • eBook
        9 7 8 0 0 8 0 5 2 6 7 0 6
      Volume 27, the first thematic volume in the Series, provides an overview of present knowledge with regard to the pharmacological and clinical aspects of antidiabetic drugs. It aims to stimulate further consideration of possible concepts in the development of new antidiabetic drugs.

    • Antioxidants in Disease Mechanisms and Therapy

      • 1st Edition
      • Volume 38
      • December 10, 1996
      • English
      • Paperback
        9 7 8 0 1 2 4 0 1 4 4 7 3
      • eBook
        9 7 8 0 0 8 0 5 8 1 3 0 9
      Antioxidants in Disease Mechanisms and Therapy presents molecular actions of natural and synthetic antioxidants and emphasizes the potential role in disease mechanisms and therapeutic strategies. The modulationof gene expression by the induction of antioxidant enzymes is a novel role beyond the direct antioxidant action. The volume explores the current state of knowledge on oxidants and antioxidants in disease processes, including arteriosclerosis, adult respiratory distress syndrome, cystic fibrosis, Down's syndrome, inflammation, cataract, age-related macular degeneration, afflications of the nervous system, AIDS, liver diseases, diabetes, skin diseases, and cancer.

    • Handbook of Perception and Action

      • 1st Edition
      • April 19, 1996
      • Wolfgang Prinz + 1 more
      • English
      • Paperback
        9 7 8 0 1 2 3 9 0 8 9 2 6
      • eBook
        9 7 8 0 0 8 0 5 3 3 6 6 7
      This volume combines the classical fields of perception research with the major theoretical attitudes of today's research, distinguishing between experience- versus performance-related approaches, transformational versus interactional approaches, and approaches that rely on the processing versus discovery of information. Perception is separated into two parts. The first part deals with basic processes and mechanisms, and discusses early vision and later, yet still basic, vision. The second covers complex achievements with accounts of perceptual constancies and the perception of patterns, objects, events, and actions.

    • Guidebook on Molecular Modeling in Drug Design

      • 1st Edition
      • April 26, 1996
      • N. Claude Cohen
      • English
      • Hardback
        9 7 8 0 1 2 1 7 8 2 4 5 0
      • eBook
        9 7 8 0 0 8 0 5 3 2 3 3 2
      Specially designed computer software is revolutionizing procedures for structured or rational drug design and discovery. The Guidebook on Molecular Modeling in Drug Design serves as a manual for the analysis ofmolecular structure and the correlation of these structures with pharmacological reactions. Intended as an introductory guide for advanced students and professionals with an interest in computer-assisted modeling for drug design and discovery, this bookwill also be of interest to medicinal and organic chemists, pharmaceutical researchers, pharmacologists, and biochemists who want to gain further insight into this rapidly advancing field.Molecular modeling is assuming an important role in the understanding of three-dimensional aspects in the specificity of drug-receptor interactions at the molecular level. This research area has become a well-established discipline in pharmaceutical research. It has created unprecedented opportunities in assisting medicinal chemists in the design of new therapeutic agents. Advances made in computer hardware and in theoretical medicinal chemistry have brought high-performance computing and graphics tools within reach of most academic and industrial laboratories, facilitating the development of useful approaches to rational drug design.The Guidebook on Molecular Modeling in Drug Design serves as a manual for the analysis of the molecular structure of biological molecules and drugs and the correlation of these structures with pharmacological actions. Intended as a guide for advanced students and professionals with an interest in computer-assisted modeling for drug design and discovery, this book will also be of interest to medicinal and organic chemists, pharmaceutical researchers, pharmacologists, and biochemists who want to gain further insight into this rapidly advancing field.

    • Advances in Pharmacology

      • 1st Edition
      • Volume 37
      • September 30, 1996
      • English
      • Paperback
        9 7 8 0 1 2 3 9 9 3 6 4 9
      • Hardback
        9 7 8 0 1 2 0 3 2 9 3 8 0
      • eBook
        9 7 8 0 0 8 0 5 8 1 2 9 3
      Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and experimental.

    • Advances in Pharmacology

      • 1st Edition
      • Volume 35
      • April 3, 1996
      • English
      • Hardback
        9 7 8 0 1 2 0 3 2 9 3 6 6
      • Paperback
        9 7 8 0 1 2 3 9 9 3 7 5 5
      • eBook
        9 7 8 0 0 8 0 5 8 1 2 7 9
      Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and experimental.

    • The SV40 Replicon Model for Analysis of Anticancer Drugs

      • 1st Edition
      • April 3, 1996
      • Robert M. Snapka
      • English
      • Hardback
        9 7 8 0 1 2 6 5 3 6 3 0 0
      • Paperback
        9 7 8 0 1 2 3 9 1 2 1 9 0
      • eBook
        9 7 8 0 0 8 0 5 5 0 1 8 3
      This book provides the most up-to-date review of the simian virus 40 (SV40) minichromosome as a model for the mammalian chromosome in studies of DNA replication. It focuses on disruption of DNA replication by anticancer drugs and DNA-damaging agents. There is a strong emphasis on the unique advantages of SV40 as an experimental system for the analysis of these classes of anticancer drug mechanisms. The new high-resolution gel electrophoresis methods for the analysis of SV40 DNA replication are covered in detail to aid readers in designing and interpreting similar experiments.

Related subjects

Biochemical pharmacology

Cardiovascular pharmacology

Clinical pharmacology therapeutics

Clinical trials

Drug adverse reactions and interactions

Endocrine exocrine pharmacology

Ethnopharmacology

Gastrointestinal pharmacology

Immunopharmacology pharmacology

Molecular pharmacology

Neoplastic cancer pharmacology

Pharmacokinetics pharmacodynamics

Pharmacology general

Principles of pharmacology

Psychoneuropharmacology

Pulmonary pharmacology

Renal and electrolyte pharmacology